1. Home
  2. RNW vs NRIX Comparison

RNW vs NRIX Comparison

Compare RNW & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$4.83

Market Cap

1.7B

Sector

Utilities

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.26

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
NRIX
Founded
2011
2009
Country
United Kingdom
United States
Employees
4336
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RNW
NRIX
Price
$4.83
$16.26
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
$7.00
$30.50
AVG Volume (30 Days)
823.4K
1.2M
Earning Date
02-16-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$11.50
$40.12
P/E Ratio
$14.63
N/A
Revenue Growth
N/A
99.31
52 Week Low
$4.39
$8.20
52 Week High
$8.24
$22.50

Technical Indicators

Market Signals
Indicator
RNW
NRIX
Relative Strength Index (RSI) 44.41 56.34
Support Level $4.39 $14.61
Resistance Level $5.58 $16.47
Average True Range (ATR) 0.14 1.01
MACD 0.03 0.15
Stochastic Oscillator 71.03 67.63

Price Performance

Historical Comparison
RNW
NRIX

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: